Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Liz McKee Anderson
AddedMar 31, 2024
UpdatedMay 31, 2026
Liz McKee Anderson

Liz McKee Anderson

Board Member, Revolution Medicines

CrunchbaseLinkedIn

Liz McKee Anderson's Career

Revolution Medicines
Revolution Medicines

Redwood City, CA, US

Board Member· Board
Insmed
Insmed

Bridgewater Township, NJ, US

Board Member· Board
BioMarin
BioMarin

San Rafael, CA, US

Board Member· Board
Aro Biotherapeutics
Aro Biotherapeutics

Philadelphia, PA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Liz McKee Anderson's Career

Revolution Medicines
Revolution Medicines
Public$1.1B2462014Redwood City, CA, US
Board Member· Board

Recent news

Reed Jobs would rather talk about curing cancer than his last nameTechCrunch · 2026

Leadership at Revolution Medicines

Barbara WeberBarbara WeberBoard Member
Martin BurkeMartin BurkeBoard Member
Eric T. SchmidtEric T. SchmidtBoard Member
Mark A. GoldsmithMark A. GoldsmithBoard Member
Kevan ShokatKevan ShokatBoard Member
Vincent A. MillerVincent A. MillerBoard Member
Insmed
Insmed
Public$3B7361999Bridgewater Township, NJ, US
Board Member· Board

Leadership at Insmed

William H. LewisWilliam H. LewisBoard Member
Al AltomariAl AltomariBoard Member
Clarissa DesjardinsClarissa DesjardinsBoard Member
Graham CrookeGraham CrookeCo-Founder
Joseph LarnerJoseph LarnerCo-Founder
David Richard BrennanDavid Richard BrennanBoard Member

Similar to Insmed

PulmatrixPulmatrixLexington, MA, USTherapeuticsest. 2003PulmatrixLexington, MA, US · est. 2003

Pulmatrix, Inc.: A US-based biotech firm specializing in therapies for chronic respiratory diseases.

Public · $148.4M24
MediciNovaMediciNovaLos Angeles, CA, USTherapeuticsest. 2000MediciNovaLos Angeles, CA, US · est. 2000

US-based MediciNova develops small molecule therapeutics for various diseases, focusing on the US market.

Public · $136M13
MannKindMannKindDanbury, CT, USPharmaceuticals, Therapeuticsest. 1991MannKindDanbury, CT, US · est. 1991

MannKind Corp: A Connecticut-based biopharmaceutical firm specializing in diabetes and pulmonary treatments.

Public233
Bristol Myers SquibbBristol Myers SquibbNew York City, NY, USPharmaceuticalsest. 1887Bristol Myers SquibbNew York City, NY, US · est. 1887

Leading American pharmaceutical company specializing in research and development.

Public · $10.6B34.3k
BioMarin
BioMarin
Public$585.8M3.1k1997San Rafael, CA, US
Board Member· Board

Leadership at BioMarin

David PyottDavid PyottBoard Member
Willard DereWillard DereBoard Member
Randy MeierRandy MeierBoard Member
Alexander HardyAlexander HardyCEO
Mark AllesMark AllesBoard Member
Christopher M. StarrChristopher M. StarrCo-Founder

Similar to BioMarin

BioCryst PharmaceuticalsBioCryst PharmaceuticalsDurham, NC, USPharmaceuticalsest. 1986BioCryst PharmaceuticalsDurham, NC, US · est. 1986

BioCryst Pharmaceuticals: A global biotech firm innovating oral treatments for rare diseases.

Public · $1.8B531
Marinus PharmaceuticalsMarinus PharmaceuticalsRadnor, PA, USMedical Drugsest. 2003Marinus PharmaceuticalsRadnor, PA, US · est. 2003

US-based Marinus Pharmaceuticals develops and commercializes medical drugs for serious neurological and psychiatric disorders.

Public · $406.9M151
Ionis PharmaceuticalsIonis PharmaceuticalsCarlsbad, CA, USPharmaceuticalsest. 1989Ionis PharmaceuticalsCarlsbad, CA, US · est. 1989

Ionis Pharmaceuticals: A US-based biotech firm specializing in RNA-targeted drug discovery for unmet needs.

Public · $1.3B796
PTC TherapeuticsPTC TherapeuticsSouth Plainfield, NJ, USPharmaceuticalsest. 1998PTC TherapeuticsSouth Plainfield, NJ, US · est. 1998

PTC Therapeutics, Inc.: A US-based pharmaceutical company specializing in oral, small-molecule drugs for genetic disorders, oncology, and infectious diseases.

Public · $1.6B1.4k
Aro Biotherapeutics
Aro Biotherapeutics
Series B$166.5M482018Philadelphia, PA, US
Board Member· Board

Leadership at Aro Biotherapeutics

Ronald V. SwansonRonald V. SwansonBoard Member
Susan DillonSusan DillonCo-Founder
Karyn ONeilKaryn ONeilCo-Founder
Bruce PeacockBruce PeacockBoard Member
Karyn O’NeilKaryn O’NeilCo-Founder

Liz McKee Anderson's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoSean JohSean JohBoard Member · Kakao

People Similar to Liz McKee Anderson

Patrick HeronPatrick HeronBoard Member · Arcutis BiotherapeuticsDoug GivenDoug GivenBoard Member · Arrowhead PharmaceuticalsCaley CasteleinCaley CasteleinFounder · Kearny Venture Partners